Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Crohn's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06455267
What this trial is testing

Preliminary Clinical Study on the Effect of L-ornithine on the Efficacy of Ustekinumab in Patients With Crohn's Disease

Who this might be right for
Mild to Severe Crohns Disease
The Third Xiangya Hospital of Central South University 50
Large-scale testing (Phase 3)Study completedNCT00207675
What this trial is testing

The Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease

Who this might be right for
Crohn Disease
Centocor, Inc. 112
Post-approval studies (Phase 4)Looking for participantsNCT06581328
What this trial is testing

Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 200
Testing effectiveness (Phase 2)UnknownNCT02335281
What this trial is testing

Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseaseUlcerative ColitisCrohn's Disease
Yanling Wei 40
Early research (Phase 1)Study completedNCT05078879
What this trial is testing

Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency

Who this might be right for
Crohn's DiseaseGlycogen MetabolismInflammatory Bowel Disease (IBD)
National Institute of Allergy and Infectious Diseases (NIAID) 4
Not applicableActive Not RecruitingNCT02130362
What this trial is testing

A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie 1,446
Large-scale testing (Phase 3)Study completedNCT01951326
What this trial is testing

Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease

Who this might be right for
Crohn's Disease
RedHill Biopharma Limited 331
Testing effectiveness (Phase 2)Study completedNCT00630643
What this trial is testing

NI-0401 in Active Crohn's Disease

Who this might be right for
Moderate to Severe Crohn's Disease
Light Chain Bioscience - Novimmune SA 40
Large-scale testing (Phase 3)Looking for participantsNCT06937099
What this trial is testing

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Who this might be right for
Crohn's DiseaseObesity or Overweight
Eli Lilly and Company 290
Testing effectiveness (Phase 2)Study completedNCT01393626
What this trial is testing

Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Pfizer 280
Testing effectiveness (Phase 2)UnknownNCT03944447
What this trial is testing

Outcomes Mandate National Integration With Cannabis as Medicine

Who this might be right for
Chronic PainChronic Pain SyndromeChronic Pain Due to Injury+30 more
OMNI Medical Services, LLC 200,000
Testing effectiveness (Phase 2)Ended earlyNCT02209792
What this trial is testing

Dose Finding Study of BIRB 796 BS in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Boehringer Ingelheim 284
Testing effectiveness (Phase 2)Looking for participantsNCT06721962
What this trial is testing

Treatment of Moderate to Severe Refractory Crohn's Disease

Who this might be right for
Crohns Disease
Tr1X, Inc. 39
Testing effectiveness (Phase 2)Ended earlyNCT05688852
What this trial is testing

VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Ventyx Biosciences, Inc 107
Large-scale testing (Phase 3)Study completedNCT00356408
What this trial is testing

Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's Disease

Who this might be right for
Crohn's Disease
UCB Pharma 106
Large-scale testing (Phase 3)Study completedNCT02914561
What this trial is testing

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Lakefront Biotherapeutics NV 1,372
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Not applicableStudy completedNCT01083680
What this trial is testing

Effectiveness and Safety in Patients With Crohn´s Disease in Clinical Routine

Who this might be right for
Crohn's Disease
AbbVie (prior sponsor, Abbott) 4,107
Testing effectiveness (Phase 2)Study completedNCT01714726
What this trial is testing

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

Who this might be right for
Crohn's Disease
AstraZeneca 121
Large-scale testing (Phase 3)Active Not RecruitingNCT06063967
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.

Who this might be right for
Crohn's Disease
AbbVie 289
Next Page